litlas
ログインアカウント作成

Joaquim Bellmunt

1993–2025 年に発表

232
論文数
59,447
被引用数
108
h 指数
212
i10 指数

被引用数

Joaquim Bellmunt の年別被引用数1976 年: 被引用 1 件1985 年: 被引用 1 件1991 年: 被引用 1 件1995 年: 被引用 1 件1996 年: 被引用 2 件1997 年: 被引用 1 件1998 年: 被引用 1 件1999 年: 被引用 4 件2000 年: 被引用 4 件2001 年: 被引用 12 件2002 年: 被引用 5 件2003 年: 被引用 5 件2004 年: 被引用 9 件2005 年: 被引用 8 件2006 年: 被引用 12 件2007 年: 被引用 15 件2008 年: 被引用 17 件2009 年: 被引用 36 件2010 年: 被引用 57 件2011 年: 被引用 131 件2012 年: 被引用 180 件2013 年: 被引用 197 件2014 年: 被引用 271 件2015 年: 被引用 359 件2016 年: 被引用 547 件2017 年: 被引用 772 件2018 年: 被引用 835 件2019 年: 被引用 2,659 件2020 年: 被引用 2,864 件2021 年: 被引用 2,634 件2022 年: 被引用 1,929 件2023 年: 被引用 1,449 件2024 年: 被引用 2,277 件2025 年: 被引用 1,004 件2026 年: 被引用 26 件1977〜1984 年は被引用が無いため表示していません1986〜1990 年は被引用が無いため表示していません1992〜1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,606 件、この内訳の 21.6%中国: 引用元論文 2,631 件、この内訳の 12.4%イタリア: 引用元論文 1,379 件、この内訳の 6.5%イギリス: 引用元論文 1,269 件、この内訳の 6%ドイツ: 引用元論文 1,216 件、この内訳の 5.7%フランス: 引用元論文 1,010 件、この内訳の 4.7%カナダ: 引用元論文 832 件、この内訳の 3.9%オランダ: 引用元論文 786 件、この内訳の 3.7%スペイン: 引用元論文 768 件、この内訳の 3.6%日本: 引用元論文 706 件、この内訳の 3.3%スイス: 引用元論文 518 件、この内訳の 2.4%オーストラリア: 引用元論文 448 件、この内訳の 2.1%
0%21.6%その他 24.1%

機関

分野

  • Medicine78.2%
  • Biochemistry, Genetics and Molecular Biology14.8%
  • Immunology and Microbiology3.3%
  • Engineering1.1%
  • Computer Science0.7%
  • Materials Science0.3%
  • その他1.6%

トピック

  • Cancer Immunotherapy and Biomarkers11.1%
  • Bladder and Urothelial Cancer Treatments8.3%
  • Prostate Cancer Treatment and Research5.8%
  • Prostate Cancer Diagnosis and Treatment5.3%
  • Urinary and Genital Oncology Studies3.6%
  • Immunotherapy and Immune Responses3%
  • その他62.9%

共著者

全論文

検索で開く
  1. Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

    著者: Joaquim Bellmunt, Ronald de Wit, David J. Vaughn, Yves Fradet, Jae‐Lyun Lee, Lawrence Fong, Nicholas J. Vogelzang, Miguel Ángel Climent, Daniel P. Petrylak, Toni K. Choueiri, Andrea Necchi, Winald R. Gerritsen, Howard Gurney, David I. Quinn, Stéphane Culine, Cora N. Sternberg, Yabing Mai, Christian Poehlein, Rodolfo F. Perini, Dean F. Bajorin - New England Journal of Medicine 2017 被引用: 3,390

  2. Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma

    著者: Thomas Powles, Se Hoon Park, Éric Voog, Claudia Caserta, Begoña P. Valderrama, Howard Gurney, Haralabos P. Kalofonos, Siniša Radulović, Wim Demey, Anders Ullén, Yohann Loriot, Srikala S. Sridhar, Norihiko Tsuchiya, Evgeny Kopyltsov, Cora N. Sternberg, Joaquim Bellmunt, Jeanny B. Aragon‐Ching, Daniel P. Petrylak, Robert J Laliberte, Jing Wang, Bo Huang, Craig B. Davis, Camilla Fowst, Nuno Costa, John A. Blake-Haskins, Alessandra di Pietro, Petros Grivas - New England Journal of Medicine 2020 被引用: 1,479

  3. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

    著者: A. Gordon Robertson, Jaegil Kim, Hikmat Al‐Ahmadie, Joaquim Bellmunt, Guangwu Guo, Andrew D. Cherniack, Toshinori Hinoue, Peter W. Laird, Katherine A. Hoadley, Rehan Akbani, Mauro A. A. Castro, Ewan A. Gibb, Rupa S. Kanchi, Dmitry A. Gordenin, Sachet A. Shukla, Francisco Sánchez-Vega, Donna E. Hansel, Bogdan Czerniak, Victor E. Reuter, Xiaoping Su, Benílton de Sá Carvalho, Vinicius S Chagas, Karen Mungall, Sara Sadeghi, Chandra Sekhar Pedamallu, Yiling Lu, Leszek J. Klimczak, Jiexin Zhang, Caleb Choo, Akinyemi I. Ojesina, Susan Bullman, Kristen Leraas, Tara M. Lichtenberg, Catherine J. Wu, N. Schultz, Gad Getz, Matthew Meyerson, Gordon B. Mills, David J. McConkey, Rehan Akbani, Hikmat Al‐Ahmadie, Monique Albert, Iakovina Alexopoulou, Adrian Ally, Tatjana Antic, Manju Aron, Miruna Balasundaram, John M.S. Bartlett, Stephen B. Baylin, Allison Beaver, Joaquim Bellmunt, İnanç Birol, Lori Boice, Moiz S. Bootwalla, Jay Bowen, Reanne Bowlby, Denise Brooks, Bradley M. Broom, Wiam Bshara, Susan Bullman, Eric Burks, Flavio Mavignier Cárcano, Rebecca Carlsen, Benilton S. Carvalho, André Lopes Carvalho, Eric Castle, Mauro A. A. Castro, Patricia Castro, James W.F. Catto, Vinicius S Chagas, Andrew D. Cherniack, David Chesla, Caleb Choo, Eric Chuah, Sudha Chudamani, Victoria K. Cortessis, Sandra Cottingham, Daniel Crain, Erin Curley, Bogdan Czerniak, Siamak Daneshmand, John A. Demchok, Noreen Dhalla, Hooman Djaladat, John Eckman, Sophie Egea, Jay Engel, Ina Felau, Martin L. Ferguson, Johanna Gardner, Julie M. Gastier‐Foster, Mark Gerken, Gad Getz, Ewan A. Gibb, Carmen Gomez‐Fernandez, Dmitry A. Gordenin, Guangwu Guo, Donna E. Hansel, Jodi Harr, Arndt Hartmann ほか 113 名 - Cell 2017 被引用: 2,535

  4. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

    著者: Jonathan E. Rosenberg, Jean Hoffman‐Censits, Tom Powles, Michiel S. van der Heijden, Arjun Vasant Balar, Andrea Necchi, Nancy A. Dawson, Peter H. O’Donnell, Ani Sarkis Balmanoukian, Yohann Loriot, Sandy Srinivas, Margitta Retz, Petros Grivas, Richard W. Joseph, Matthew D. Galsky, Mark T. Fleming, Daniel P. Petrylak, José Luis Perez‐Gracia, Howard A. Burris, Daniel Castellano, Christina Canil, Joaquim Bellmunt, Dean F. Bajorin, Dorothee Nickles, Richard Bourgon, Garrett M. Frampton, Na Cui, Sanjeev Mariathasan, Oyewale O. Abidoye, Gregg Fine, Robert Dreicer - The Lancet 2016 被引用: 3,714

  5. Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial

    著者: Arjun Vasant Balar, Matthew D. Galsky, Jonathan E. Rosenberg, Thomas Powles, Daniel P. Petrylak, Joaquim Bellmunt, Yohann Loriot, Andrea Necchi, Jean Hoffman‐Censits, José Luis Perez‐Gracia, Nancy A. Dawson, Michiel S. van der Heijden, Robert Dreicer, Sandy Srinivas, Margitta Retz, Richard W. Joseph, Alexandra Drakaki, Ulka N. Vaishampayan, Srikala S. Sridhar, David I. Quinn, Ignacio Durán, David R. Shaffer, Bernhard J. Eigl, Petros Grivas, Evan Y. Yu, Shi Li, Edward E. Kadel, Zachary Boyd, Richard Bourgon, Priti S. Hegde, Sanjeev Mariathasan, AnnChristine Thåström, Oyewale O. Abidoye, Gregg Fine, Dean F. Bajorin - The Lancet 2016 被引用: 2,211

  6. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer

    著者: Aurélie Kamoun, Aurélien de Reyniès, Yves Allory, Gottfrid Sjödahl, A. Gordon Robertson, Roland Seiler, Katherine A. Hoadley, Clarice S. Groeneveld, Hikmat Al-Ahmadie, Woonyoung Choi, Mauro A.A. Castro, Jacqueline Fontugne, Pontus Eriksson, Qianxing Mo, Jordan Kardos, Alexandre Zlotta, Arndt Hartmann, Colin P. Dinney, Joaquim Bellmunt, Thomas Powles, Núria Malats, Keith Syson Chan, William Y. Kim, David J. McConkey, Peter C. Black, Lars Dyrskjøt, Mattias Höglund, Seth P. Lerner, Francisco X. Real, François Radvanyi, Mattias Aine, Hikmat Al-Ahmadie, Yves Allory, Joaquim Bellmunt, Isabelle Bernard-Pierrot, Peter C. Black, Mauro A.A. Castro, Keith Syson Chan, Woonyoung Choi, Bogdan Czerniak, Colin P. Dinney, Lars Dyrskjøt, Pontus Eriksson, Jacqueline Fontugne, Ewan A. Gibb, Clarice S. Groeneveld, Arndt Hartmann, Katherine A. Hoadley, Mattias Höglund, Aurélie Kamoun, Jordan Kardos, Jaegil Kim, William Y. Kim, David J. Kwiatkowski, Thierry Lebrét, Seth P. Lerner, Fredrik Liedberg, Núria Malats, David J. McConkey, Qianxing Mo, Thomas Powles, François Radvanyi, Francisco X. Real, Aurélien de Reyniès, A. Gordon Robertson, Arlene O. Siefker‐Radtke, Nanor Sirab, Roland Seiler, Gottfrid Sjödahl, Ann Taber, John N. Weinstein, Alexandre Zlotta - European Urology 2019 被引用: 1,360

  7. ctDNA guiding adjuvant immunotherapy in urothelial carcinoma

    著者: Thomas Powles, Zoe J. Assaf, Nicole N. Davarpanah, Romain Banchereau, Bernadett Szabados, Kobe Yuen, Petros Grivas, Maha Hussain, Stéphane Oudard, Jürgen E. Gschwend, Peter Albers, Daniel Castellano, Hiroyuki Nishiyama, Siamak Daneshmand, Shruti Sharma, Bernhard Zimmermann, Himanshu Sethi, Alexey Aleshin, Maurizio Perdicchio, Jingbin Zhang, David S. Shames, Viraj Degaonkar, Xiaodong Shen, Corey Carter, Carlos Bais, Joaquim Bellmunt, Sanjeev Mariathasan - Nature 2021 被引用: 629

  8. Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    著者: Tom Powles, Joaquim Bellmunt, Éva Compérat, Maria De Santis, Robert Huddart, Yohann Loriot, Andrea Necchi, Begoña P. Valderrama, Alain Ravaud, Shahrokh F. Shariat, Bernadett Szabados, Michiel S. van der Heijden, Silke Gillessen - Annals of Oncology 2021 被引用: 525

  9. First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study

    著者: Arjun Vasant Balar, Daniel Castellano, Peter H. O’Donnell, Petros Grivas, Jacqueline Vuky, Thomas Powles, Elizabeth R. Plimack, Noah M. Hahn, Ronald de Wit, Lei Pang, Mary J. Savage, Rodolfo F. Perini, Stephen J. O’Keefe, Dean F. Bajorin, Joaquim Bellmunt - The Lancet Oncology 2017 被引用: 1,342

  10. MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

    著者: Thomas Powles, Joseph P. Eder, Gregg Fine, Fadi S. Braiteh, Yohann Loriot, Cristina Cruz, Joaquim Bellmunt, Howard A. Burris, Daniel P. Petrylak, Siew-leng Melinda Teng, Xiaodong Shen, Zachary Boyd, Priti S. Hegde, Daniel S. Chen, Nicholas J. Vogelzang - Nature 2014 被引用: 2,430

  11. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

    著者: Nicolas Mottet, Joaquim Bellmunt, M. Bolla, Erik Briers, Marcus Cumberbatch, Maria De Santis, Nicola Fossati, Tobias Gross, Ann Henry, Steven Joniau, Thomas Lam, Malcolm D. Mason, В. Б. Матвеев, Paul C. Moldovan, Roderick C.N. van den Bergh, Thomas Van den Broeck, Henk G. van der Poel, Theodorus van der Kwast, Olivier Rouvière, Ivo G. Schoots, Thomas Wiegel, Philip Cornford - European Urology 2016 被引用: 3,260

  12. Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

    著者: Thomas Powles, Michiel S. van der Heijden, Daniel Castellano, Matthew D. Galsky, Yohann Loriot, Daniel P. Petrylak, Osamu Ogawa, Se Hoon Park, Jae‐Lyun Lee, Ugo De Giorgi, Martin Bögemann, Aristotelis Bamias, Bernhard J. Eigl, Howard Gurney, Som D. Mukherjee, Yves Fradet, Iwona Skoneczna, Marinos Tsiatas, Andrey Novikov, Cristina Suárez, André P. Fay, Ignacio Durán, Andrea Necchi, Sophie Wildsmith, Philip He, Natasha Angra, Ashok Gupta, Wendy J. Levin, Joaquim Bellmunt, Se Hoon Park, Michiel S. van der Heijden, Andrea Necchi, Daniel Castellano, Aristotelis Bamias, Jae‐Lyun Lee, Ugo De Giorgi, Martin Bögemann, Bernhard J. Eigl, Marinos Tsiatas, Thomas Powles, Andrey Novikov, Iwona Skoneczna, Som D. Mukherjee, Cristina Suárez, Hans M. Westgeest, Yves Fradet, Aude Fléchon, Yen‐Chuan Ou, Inkeun Park, Vsevolod Matveev, Begoña Pérez‐Valderrama, Susanna Cheng, Stephen Jay Frank, Howard Gurney, Urbano Anido, Alketa Hamzaj, Margitta Retz, Srikala S. Sridhar, Giorgio V. Scagliotti, Jens Voortman, B. Yа. Alekseev, Anna Alyasova, B. K. Komyakov, Herlinde Dumez, Michel Pavic, Go Kimura, Atsushi Mizokami, Susanne Osanto, José Ángel Arranz, Djura Piersma, Sang Joon Shin, O. B. Karyakin, Ignacio Delgado, José Luis González, See‐Tong Pang, Anna Tran, Oleg Lipatov, Wen-Pin Su, Thomas W. Flaig, Ajjai Alva, Hwa Park Kyong, Evgeny Kopyltsov, Elena Almagro, M. Doménech, Yen‐Hwa Chang, Brieuc Sautois, Andre Ravaux, Gerasimos Aravantinos, V. Georgoulias, Sasja F. Mulder, Yu Jung Kim, Fabio Kater, Christine Chevreau, Scott T. Tagawa, Paweł Zalewski, Florence Joly, Yohann Loriot, Gencay Hatiboglu, Luca Gianni, Franco Morelli ほか 127 名 - The Lancet Oncology 2020 被引用: 498

  13. Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial

    著者: Joaquim Bellmunt, Maha Hussain, Jürgen E. Gschwend, Peter Albers, Stéphane Oudard, Daniel Castellano, Siamak Daneshmand, Hiroyuki Nishiyama, Martin Majchrowicz, Viraj Degaonkar, Yi Shi, Sanjeev Mariathasan, Petros Grivas, Alexandra Drakaki, Peter H. O’Donnell, Jonathan E. Rosenberg, Daniel M. Geynisman, Daniel P. Petrylak, Jean Hoffman‐Censits, Jens Bedke, Arash Rezazadeh Kalebasty, Yousef Zakharia, Michiel S. van der Heijden, Cora N. Sternberg, Nicole N. Davarpanah, Thomas Powles - The Lancet Oncology 2021 被引用: 412

  14. Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up

    著者: Thomas Powles, Se Hoon Park, Claudia Caserta, Begoña P. Valderrama, Howard Gurney, Anders Ullén, Yohann Loriot, Srikala S. Sridhar, Cora N. Sternberg, Joaquim Bellmunt, Jeanny B. Aragon‐Ching, Jing Wang, Bo Huang, Robert J Laliberte, Alessandra di Pietro, Petros Grivas - Journal of Clinical Oncology 2023 被引用: 211

  15. Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer

    著者: Paloma Cejas, Yingtian Xie, Alba Font‐Tello, Klothilda Lim, Sudeepa Syamala, Xintao Qiu, Alok K. Tewari, Neel Shah, Holly M. Nguyen, Radhika A. Patel, Lisha G. Brown, Ilsa M. Coleman, Wenzel M. Hackeng, Lodewijk A.A. Brosens, Koen M.A. Dreijerink, Leigh Ellis, Sarah Abou Alaiwi, Ji-Heui Seo, Sylvan C. Baca, Himisha Beltran, Francesca Khani, Mark M. Pomerantz, Alessandra Dall’Agnese, Jett Crowdis, Eliezer M. Van Allen, Joaquim Bellmunt, Colm Morrisey, Peter S. Nelson, James A. DeCaprio, Anna F. Farago, Nicholas J. Dyson, Benjamin J. Drapkin, X. Shirley Liu, Matthew L. Freedman, Michael C. Haffner, Eva Corey, Myles Brown, Henry W. Long - Nature Communications 2021 被引用: 161

  16. Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy

    著者: Matthew D. Galsky, Noah M. Hahn, Jonathan Rosenberg, Guru Sonpavde, Thomas E. Hutson, William Oh, Robert Dreicer, Nicholas J. Vogelzang, Cora N. Sternberg, Dean F. Bajorin, Joaquim Bellmunt - Journal of Clinical Oncology 2011 被引用: 688

  17. Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    著者: Joaquim Bellmunt, Anna Orsola, Thomas Wiegel, Marta Guix, Maria De Santis, Vesa Kataja - Annals of Oncology 2011 被引用: 249

  18. Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors

    著者: Diana Miao, Claire A. Margolis, Natalie I. Vokes, David Liu, Amaro Taylor‐Weiner, Stephanie A. Wankowicz, Dennis O. Adeegbe, Daniel Keliher, Bastian Schilling, Adam Tracy, Michael P. Manos, Nicole G. Chau, Glenn J. Hanna, Paz Polak, Scott J. Rodig, Sabina Signoretti, Lynette M. Sholl, Jeffrey A. Engelman, Gad Getz, Pasi A. Jänne, Robert I. Haddad, Toni K. Choueiri, David A. Barbie, Rizwan Haq, Mark M. Awad, Dirk Schadendorf, F. Stephen Hodi, Joaquim Bellmunt, Kwok‐Kin Wong, Peter S. Hammerman, Eliezer M. Van Allen - Nature Genetics 2018 被引用: 696

  19. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer

    著者: Philip Cornford, Joaquim Bellmunt, M. Bolla, Erik Briers, Maria De Santis, Tobias Gross, Ann Henry, Steven Joniau, Thomas Lam, Malcolm D. Mason, Henk G. van der Poel, Theodorus van der Kwast, Olivier Rouvière, Thomas Wiegel, Nicolas Mottet - European Urology 2016 被引用: 1,442

  20. The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma

    著者: Bradley A. McGregor, Guru Sonpavde, Lucia Kwak, Meredith M. Regan, Xīn Gào, H. Hvidsten, Charlene Mantia, Xiao X. Wei, J.E. Berchuck, Stephanie Berg, Praful Ravi, M. Dror Michaelson, Toni K. Choueiri, Joaquim Bellmunt - Annals of Oncology 2023 被引用: 86

  21. Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up

    著者: Yves Fradet, Joaquim Bellmunt, David J. Vaughn, J L Lee, Lawrence Fong, Nicholas J. Vogelzang, M.Á. Climent, Daniel P. Petrylak, Toni K. Choueiri, Andrea Necchi, Winald R. Gerritsen, Howard Gurney, David I. Quinn, Stéphane Culine, Cora N. Sternberg, K. Nam, Tara L. Frenkl, Rodolfo F. Perini, Ronald de Wit, Dean F. Bajorin - Annals of Oncology 2019 被引用: 488

  22. Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma

    著者: Thomas Powles, Zoe J. Assaf, Viraj Degaonkar, Petros Grivas, Maha Hussain, Stéphane Oudard, Jürgen E. Gschwend, Peter Albers, Daniel Castellano, Hiroyuki Nishiyama, Siamak Daneshmand, Shruti Sharma, Himanshu Sethi, Alexey Aleshin, Yi Shi, Nicole N. Davarpanah, Corey Carter, Joaquim Bellmunt, Sanjeev Mariathasan - European Urology 2023 被引用: 131

  23. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review

    著者: Nicola Fossati, Peter-Paul Willemse, Thomas Van den Broeck, Roderick C.N. van den Bergh, Cathy Yuhong Yuan, Erik Briers, Joaquim Bellmunt, M. Bolla, Philip Cornford, Maria De Santis, Ekelechi MacPepple, Ann Henry, Malcolm D. Mason, В. Б. Матвеев, Henk G. van der Poel, Theodorus van der Kwast, Olivier Rouvière, Ivo G. Schoots, Thomas Wiegel, Thomas Lam, Nicolas Mottet, Steven Joniau - European Urology 2017 被引用: 533

  24. ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma

    著者: Thomas Powles, Joaquim Bellmunt, Éva Compérat, Maria De Santis, Robert Huddart, Yohann Loriot, Andrea Necchi, Begoña P. Valderrama, Alain Ravaud, Shahrokh F. Shariat, Bernadett Szabados, Michiel S. van der Heijden, Silke Gillessen - Annals of Oncology 2024 被引用: 159